Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 16,596 | 251 | N/A | N/A |
| Other current assets | 2,105 | 0 | 0 | 0 |
| TOTAL | $20,076 | $502 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,266 | 268 | N/A | N/A |
| Other Non-Current Assets | 86 | 447 | 0 | 0 |
| TOTAL | $1,352 | $715 | $N/A | $N/A |
| Total Assets | $21,428 | $1,217 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 16,055 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,882 | 3,547 | 0 | 0 |
| Accrued Expenses | N/A | 1,398 | N/A | N/A |
| Other current liabilities | 916 | 714 | N/A | N/A |
| TOTAL | $4,830 | $21,714 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 567 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 72,388 | 48,165 | 0 | 0 |
| TOTAL | $73,041 | $48,165 | $N/A | $N/A |
| Total Liabilities | $77,871 | $69,879 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -112,412 | -92,312 | N/A | N/A |
| TOTAL | $-56,443 | $-68,662 | $N/A | $N/A |
| Total Liabilities And Equity | $21,428 | $1,217 | $0 | $0 |